Get started
Author

Trond Espen Detlie

Observed names: Detlie TE, Detlie, T. E., Detlie, Trond Espen, T Detlie, T E Detlie, T. E. Detlie, T.E. Detlie, Trond E Detlie, Trond E. Detlie
ORCID: 0000-0002-1576-5298
Observed ORCID: 0000-0002-1576-5298
OpenAlex ID: A5088340702
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
2016 · N. T. Ventham, N. A. Kennedy, et al. · Nature Communications · 255
PDF
Systemic Inflammation in Preclinical Ulcerative Colitis
2021 · Daniel Bergemalm, Erik Andersson, et al. · Gastroenterology · 129
PDF
Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study
2015 · Jørgen Jahnsen, Trond Espen Detlie, et al. · Expert Review of Gastroenterology & Hepatology · 111
PDF
Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside
2019 · Trond Espen Detlie, Jonas Christoffer Lindstrøm, et al. · Alimentary Pharmacology & Therapeutics · 68
PDF
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2
2022 · Jan K Nowak, Alex T Adams, et al. · Journal of Crohn s and Colitis · 51
PDF
Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome
2022 · Rahul Kalla, Alex T Adams, et al. · Journal of Crohn s and Colitis · 50
PDF
Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)
2020 · S. Vatn, A. Carstens, et al. · Scandinavian Journal of Gastroenterology · 45
PDF
Review article: treating‐to‐target for inflammatory bowel disease‐associated anaemia
2018 · Laurent Peyrin‐Biroulet, Anthony Lopez, et al. · Alimentary Pharmacology & Therapeutics · 38
PDF
Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway
2021 · Vendel A. Kristensen, Randi Opheim, et al. · Scandinavian Journal of Gastroenterology · 35
PDF
Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III Study
2023 · Kristina I Aass Holten, Tomm Bernklev, et al. · Journal of Crohn s and Colitis · 31
PDF
The prevalence and transcriptional activity of the mucosal microbiota of ulcerative colitis patients
2018 · Aina E. Fossum Moen, Jonas Christoffer Lindstrøm, et al. · Scientific Reports · 25
PDF
Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
2023 · Ingunn Johansen, Milada Cvancarova Småstuen, et al. · BMC Gastroenterology · 24
PDF
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease
2024 · Samira Salihovic, Niklas Nyström, et al. · Nature Communications · 22
PDF
Health-related quality of life in patients with newly diagnosed inflammatory bowel disease: an observational prospective cohort study (IBSEN III)
2023 · Bjorn Christian Olsen, Randi Opheim, et al. · Quality of Life Research · 16
PDF
Treatment and outcome of gastrointestinal bleeding due to peptic ulcers and erosions – (BLUE study)
2021 · Katrine Kauczynska Romstad, Trond Espen Detlie, et al. · Scandinavian Journal of Gastroenterology · 13
PDF
Gastrointestinal bleeding due to peptic ulcers and erosions – a prospective observational study (BLUE study)
2020 · Katrine Kauczynska Romstad, Trond Espen Detlie, et al. · Scandinavian Journal of Gastroenterology · 13
PDF
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype
2025 · Eleftheria Pertsinidou, Benita Salomon, et al. · Journal of Crohn s and Colitis · 11
PDF
Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study)
2024 · Kristina A Holten, Tomm Bernklev, et al. · Journal of Crohn s and Colitis · 11
Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact
2021 · Trond Espen Detlie, Jonas Christoffer Lindstrøm, et al. · World Journal of Gastroenterology · 11
Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis—results from the IBSEN III inception cohort
2024 · Vibeke Strande, Charlotte Lund, et al. · Alimentary Pharmacology & Therapeutics · 9
Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort)
2025 · Bjorn Christian Olsen, Randi Opheim, et al. · Inflammatory Bowel Diseases · 8
Dietary intake and nutritional status in patients with newly diagnosed inflammatory bowel disease: insights from the IBSEN III study
2024 · Insaf Zerouga, Jørgen Valeur, et al. · Scandinavian Journal of Gastroenterology · 7
Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stages
2026 · Aya K.H. Mahdy, Hesham ElAbd, et al. · Genome Medicine · 6
PDF
Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort
2025 · Simen Hyll Hansen, Maria Gjerstad Maseng, et al. · Inflammatory Bowel Diseases · 5
PDF
Low Surgery Rates in Early Crohn’s Disease: Results from a Prospective Population-Based Inception Cohort—The Inflammatory Bowel Disease in South-Eastern Norway III Study
2024 · Charlotte Lund, Vibeke Strande, et al. · Inflammatory Bowel Diseases · 5
PDF
Works count: 87
Citation count: 1,040
H-index: 14
I10-index: 19
Year
Topic
Type